EFFICACY AND SAFETY OF PONATINIB USED IN FRAIL CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS OUTSIDE OF CLINICAL TRIALS

被引：0
|
作者：
Breccia, M. [1 ]
Abruzzese, E. [2 ]
Accurso, V. [3 ]
Castagnetti, F. [4 ]
Galimberti, S. [5 ]
Bonifacio, M. [6 ]
Gangemi, D. [7 ]
La Barba, G.
Sora, F. [8 ]
Tiribelli, M. [9 ]
Iurlo, A. [10 ]
Luciano, L. [11 ]
Gozzini, A. [12 ]
Pezzullo, L.
Rossi, A. Russo [13 ]
Sgherza, N. [14 ]
Foa, R. [1 ]
机构：
[1] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Policlin Umberto I, Hematol, Rome, Italy
[2] S Eugenio Hosp, Rome, Italy
[3] Policlin Giaccone, Hematol, Palermo, Italy
[4] Univ Bologna, Inst Hematol L&A Seragnoli, Univ Hosp, Bologna, Italy
[5] Pisa Univ, Hematol, Pisa, Italy
[6] Univ Verona, Sect Hematol, Dept Med, Verona, Italy
[7] Fabrizio Spaziano Hosp, Frosinone, Italy
[8] Cattolica Sacro Cuore Univ, Rome, Italy
[9] Udine Univ, Hematol, Udine, Italy
[10] Univ Milan, IRCCS Ca Granda Maggiore Policlin Hosp Fdn, Milan, Italy
[11] Federico II Univ Naples, Naples, Italy
[12] Univ Firenze, AOU Careggi, Florence, Italy
[13] Univ Bari, Hematol & Transplants Unit, Bari, Italy
[14] Casa Sollievo Sofferenza Hosp, San Giovanni Rotondo, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P096
引用
收藏
页码：89 / 90
页数：2
相关论文
共 50 条
  • [31] Ponatinib in the therapy of chronic myeloid leukemia
    Martell, Marc Poch
    Sibai, Hassan
    Deotare, Uday
    Lipton, Jeffrey H.
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (10) : 923 - 932
  • [32] Clinical Trials in Chronic Myeloid Leukemia
    Susanne Saussele
    Markus Pfirrmann
    Current Hematologic Malignancy Reports, 2012, 7 : 109 - 115
  • [33] Clinical Trials in Chronic Myeloid Leukemia
    Saussele, Susanne
    Pfirrmann, Markus
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (02) : 109 - 115
  • [34] Ponatinib in Chronic-Phase Chronic Myeloid Leukemia Patients: Final Report from a Phase 1 Trial
    Mauro, Michael J.
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Shah, Neil P.
    Bixby, Dale L.
    Flinn, Ian W.
    O'Hare, Thomas
    Rivera, Victor M.
    Lustgarten, Stephanie
    Santillana, Sergio
    Heinrich, Michael C.
    Druker, Brian J.
    Deininger, Michael W.
    Talpaz, Moshe
    BLOOD, 2016, 128 (22)
  • [35] COST-EFFECTIVENESS OF PONATINIB IN THE TREATMENT OF PATIENTS WITH CHRONIC PHASE- CHRONIC MYELOID LEUKEMIA IN GREECE
    Gourzoulidis, G.
    Kourlaba, G.
    Giannoulia, P.
    Panagiotidis, P.
    Maniadakis, N.
    VALUE IN HEALTH, 2017, 20 (09) : A435 - A435
  • [36] An evaluation of ponatinib as a therapy in adult patients with resistant/intolerant chronic-phase chronic myeloid leukemia
    Yang, Jay
    Surapaneni, Malini
    Schiffer, Charles A.
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (05) : 393 - 402
  • [37] Efficacy of Ponatinib after Multiple Lines of Therapy for Chronic Myeloid Leukemia
    Swaminathan, Mahesh
    Kantarjian, Hagop M.
    Sasaki, Koji
    Ravandi, Farhad
    Borthakur, Gautam
    Kadia, Tapan M.
    Garcia-Manero, Guillermo
    DiNardo, Courtney D.
    Konopleva, Marina Y.
    Estrov, Zeev E.
    Pemmaraju, Naveen
    Daver, Naval G.
    Wierda, William G.
    Ferrajoli, Alessandra
    Pierce, Sherry A.
    Dellasala, M. D. Emogene
    Jabbour, Elias J.
    Cortes, Jorge E.
    BLOOD, 2018, 132
  • [38] Dose Modification Dynamics of Ponatinib in Patients with Chronic- Phase Chronic Myeloid Leukemia (CP-CML) from the PACE and Optic Trials
    J.Jabbour, Elias
    W.Deininger, Michael
    bruzzese, Elisabetta A.
    Apperley, jane F.
    E.Cortes, Jorge
    Chuah, Charles
    J.DeAngelo, Daniel
    F.DiPersio, John
    Hochhaus, Andreas
    H.Lipton, Jeffrey
    E.Nicolini, Franck
    Ibarz, Javier Pinilla
    Rea, Delphine
    Rosti, Gianantonio
    Rousselot, Philippe
    J.Mauro, Michael
    Shah, Neil P.
    Talpaz, Moshe
    Vorog, Alexander
    Lu, Vickie
    Kantarjian, Hagop
    BLOOD, 2021, 138
  • [39] Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials
    Jabbour, Elias
    Apperley, Jane
    Cortes, Jorge
    Rea, Delphine
    Deininger, Michael
    Abruzzese, Elisabetta
    Chuah, Charles
    Deangelo, Daniel J.
    Hochhaus, Andreas
    Lipton, Jeffrey H.
    Mauro, Michael
    Nicolini, Franck
    Pinilla-Ibarz, Javier
    Rosti, Gianantonio
    Rousselot, Philippe
    Shah, Neil P.
    Talpaz, Moshe
    Vorog, Alexander
    Ren, Xiaowei
    Kantarjian, Hagop
    LEUKEMIA, 2024, 38 (03) : 475 - 481
  • [40] Efficacy of Imatinib Dose Escalation in Patients With Chronic Myeloid Leukemia in Chronic Phase
    Kantarjian, Hagop M.
    Larson, Richard A.
    Guilhot, Francois
    O'Brien, Stephen G.
    Mone, Manisha
    Rudoltz, Marc
    Krahnke, Tillmann
    Cortes, Jorge
    Druker, Brian J.
    CANCER, 2009, 115 (03) : 551 - 560
12345